| Issue |
Title |
File |
| Vol 3, No 2 (2001) |
Profilaktika tromboza glubokikh ven i tromboembolii legochnoy arterii u onkologicheskikh bol'nykh |
|
|
Evtyukhin A.I., Sokolovskaya N.E., Leonenkov V.V., Utesheva M.A.
|
| Vol 18, No 2 (2016) |
Prognostic factors in patients with disseminated gastrointestinal stromal tumors |
(Rus)
|
|
Arkhiri P.P., Stilidi I.S., Poddubnaya I.V., Nered S.N., Nikulin M.P., Abu-Khaydar O.B.
|
| Vol 22, No 3 (2020) |
Prognostic relevance of the TNM classification 8th edition and new criteria of staging for retroperitoneal liposarcoma |
(Rus)
|
|
Nered S.N., Volkov A.Y., Kozlov N.А., Stilidi I.S., Archery P.P.
|
| Vol 23, No 1 (2021) |
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer |
(Rus)
|
|
Samaneva N.I., Vladimirova L.I., Kolyadina I.V., Frantsiyants E.M., Storozhakova A.E., Bandovkina V.A., Kalabanova E.A., Kabanov S.N., Svetitskaya I.V., Tishina A.V., Ezhova M.O.
|
| Vol 26, No 4 (2024) |
Prognostic significance of androgen receptor expression in triple-negative breast cancer |
(Rus)
|
|
Panchenko I.S., Panchenko S.V., Sharafutdinov M.G., Rodionov V.V., Kometova V.V., Burmenskaya O.V.
|
| Vol 16, No 2 (2014) |
Prognostic significance of dynamics of biochemical markers of neuroendocrine tumors during treatment with biotherapy |
|
|
Emelianova G.S., Gorbunova V.A., Lubimova N.V., Orel N.F., Markovich A.A., Selchuk V.U.
|
| Vol 27, No 2 (2025) |
Prognostic significance of primary and interval cytoreductive surgery in late-stage ovarian cancer. A retrospective study |
(Rus)
|
|
Zhurman V.N., Nechushkina V.M., Maslennikova A.V.
|
| Vol 15, No 2 (2013) |
Prognostic value of p53 expression in patients with stage I breast cancer |
|
|
Kolyadina I.V., Poddubnaya I.V., Van de Velde C.J., Kuppen P.J., Liefers G.J., Dekker-Ensink N.G., Bastiaannet E., Van As-Sajet A., Prinse B., Engels C., Van Vlierberghe R., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Frank G.A., Banov S.M.
|
| Vol 8, No 4 (2006) |
Prognosticheskie faktory effektivnosti lecheniya retsidiva raka yaichnikov IV stadii |
|
|
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
|
| Vol 15, No 3 (2013) |
Prognosticheskoe znachenie lokal'nogo i sistemnogo lecheniya pri rake molochnoy zhelezy I stadii |
|
|
Kolyadina I.V., Poddubnaya I.V., Trofimova O.P., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Frank G.A., Banov S.M.
|
| Vol 13, No 2 (2011) |
Prognoz bilateral'nykh pervichnykhnekhodzhkinskikh limfom organa zreniya |
|
|
Poddubnaya I.V., Grishina E.E., Guzenko E.S., Gemdzhyan E.G.
|
| Vol 14, No 3 (2012) |
Prognozirovanie zabolevaemosti rakom molochnoy zhelezy s vydeleniem populyatsii patsientov s giperekspressiey HER2 v Sibirskom federal'nom okruge |
|
|
Ryazhenov V.V., Gorokhova S.G.
|
| Vol 15, No 3 (2013) |
Prolongirovannaya blokada angiogeneza pri metastaticheskom kolorektal'nom rake (novye dannye) |
|
|
Artamonova E.V.
|
| Vol 6, No 3 (2004) |
Promezhutochnye rezul'taty i perspektivy realizatsii Vserossiyskoy regional'noy programmy lecheniya mestno-rasprostranennogo i disseminirovannogo raka molochnoy zhelezy |
|
|
- -.
|
| Vol 18, No 5 (2016) |
Prospective analysis of efficacy and safety of BR regime in the first-line treatment of chronic lymphocytic leukemia |
|
|
Stadnik E.A., Strugov V.V., Andreeva T.O., Virts Y.V., Mirolyubova Y.V., Butylin P.A., Zaritskiy A.Y.
|
| Vol 16, No 3 (2014) |
Prospects for revision of the histological classification of neuroendocrine tumorsBased on the materials of 11-th Annual European Neuroendocrine Tumor Society Conference |
|
|
Gurevich L.E., Delectorskaya V.V.
|
| Vol 22, No 3 (2020) |
Prospects for the development of adjuvant therapy for non-small cell lung cancer |
(Rus)
|
|
Laktionov K.K., Kazakov A.M., Reutova E.V., Ardzinba M.S., Arzumanian A.L.
|
| Vol 24, No 2 (2022) |
Prospects for the treatment of neurofibromatosis type 1: A review |
(Rus)
|
|
Mustafin R.N.
|
| Vol 27, No 2 (2025) |
Prospects for the use of big data, artificial intelligence, machine learning, neural networks, and deep learning in the diagnosis and treatment of malignant tumors of the genitourinary system: a review |
(Rus)
|
|
Khachaturyan A.V.
|
| Vol 22, No 2 (2020) |
Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience |
(Rus)
(Eng)
|
|
Kolyadina I.V., Ganshina I.P., Kuzmicheva S.V., Tekeeva A.I., Kolokolov J.D., Volkonskii M.V., Poddubnaya I.V.
|
| Vol 23, No 2 (2021) |
Prostate cancer |
(Rus)
|
|
Kaprin A.D., Alekseev B.I., Matveev V.B., Pushkar’ D.I., Govorov A.V., Gorban’ N.A., Kirichek A.A., Biriukov V.A., Volkova M.I., Gulidov I.A., Gumenetskaia I.V., Krylov V.V., Kariakin O.B., Krasheninnikov A.A., Mardynskii I.S., Niushko K.M., Zakharova T.I., Kostin A.A., Khmelevskii E.V., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
| Vol 5, No 4 (2003) |
Protivoopukholevye vaktsiny |
|
|
Korostelev S.A.
|
| Vol 12, No 4 (2010) |
Psikhofarmakologicheskayakorrektsiya astenicheskikh rasstroystv,svyazannykh s khimioterapieyzlokachestvennykh novoobrazovaniy:opyt primeneniya Ladastena |
|
|
Shafigullin M.R.
|
| Vol 7, No 2 (2005) |
Punktsionno-dreniruyushchiy metod - effektivnoe lechenie posleoperatsionnykh khirurgicheskikh oslozhneniy v torakoabdominal'noy onkologii |
|
|
Dolgushin B.I., Pankratenko O.A., Poddubnaya I.V.
|
| Vol 13, No 3 (2011) |
Puti resheniya aktual'nykh problemneyroonkologii |
|
|
- -.
|
| Vol 8, No 4 (2006) |
Puti uluchsheniya neposredstvennykh rezul'tatov khirurgicheskogo lecheniya yukstakardial'nogo raka |
|
|
Khvastunov R.A., Shereshkov A.Y., Ivanov A.I., Mudryy A.Y.
|
| Vol 1, No 2 (1999) |
Puti uluchsheniya ranney vyyavlyaemoe™ raka molochnoy zhelezy (opyt Krasnodarskogo gorodskogo onkologicheskogo dispansera) |
|
|
Arkad'eva T.V.
|
| Vol 20, No 4 (2018) |
Quality control of immunohistochemical analyzes in Russia: yesterday, today, tomorrow |
(Rus)
|
|
Kolyadina I.V., Frank G.A., Poddubnaya I.V., Andreeva Y.Y., Zavalishina L.E.
|
| Vol 24, No 1 (2022) |
Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research |
(Rus)
|
|
Kolomejtseva A.A., Bokova S.E.
|
| Vol 21, No 2 (2019) |
Quality of life and psychological status of thoracic and abdominal pediatric cancer survivors |
(Rus)
|
|
Mikhailova S.N., Sachuk O.V., Sukhanovskaya E.N., Valiev T.T., Kazantsev A.P., Rubanskaya M.V., Pimenov R.I., Malakhova A.A., Babij E.S.
|
| Vol 17, No 1 (2015) |
Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer |
|
|
Semiglazova T.Y., Dashyan G.A., Semiglazov V.V., Zhabina A.S., Osipov M.A., Kotova Z.S., Klimenko V.V., Krivorotko P.V., Semiglazov V.F.
|
| Vol 26, No 2 (2024) |
Quantitative indicators of TREC and KREC excision circles in malignancies: a prospective cohort study |
(Rus)
|
|
Sultanbaev A.V., Musin S.I., Menshikov K.V., Sultanbaeva N.I., Tuzankina I.A., Lipatov D.O., Menshikova I.A., Sultanbaev M.V., Kudlay D.A., Prodeus A.P.
|
| Vol 25, No 2 (2023) |
Radiation induced skin reactions in primary cutaneous lymphoma patients: A review |
(Rus)
|
|
Ilyin N.V., Vinogradova Y.N., Zaslavskiy D.V., Maria M.I.
|
| Vol 25, No 4 (2023) |
Radiation injuries of organs and tissues: mechanisms of occurrence, methods of prevention and treatment: A review |
(Rus)
|
|
Balaeva D.A., Romanov D.S., Trofimova O.P., Gadzhibabaeva Z.Z., Gorchak Y.Y., Gariaev G.A.
|
| Vol 16, No 1 (2014) |
Radiation therapy as an independent method of treatment in case of carcinoma of floor of mouth |
|
|
Garbuzov M.I.
|
| Vol 22, No 4 (2020) |
Radiation therapy in treatment of Rosai–Dorfman disease: literature review and report of a patient with cutaneous form |
(Rus)
|
|
Potapenko V.G., Belousova I.E., Vinogradova J.N., Kelehsaeva K.A., Ulitin A.M., Smirnova I.O., Petunova Y.G., Ilyin N.V.
|
| Vol 16, No 4 (2014) |
Radiation treatment of the primary vulvar Pagetʼs disease: case report |
|
|
Razumova E.L., Kizhaev Y.E., Ukolova E.A.
|
| Vol 17, No 1 (2015) |
Radiation-induced lung injury in breast cancer patients after breast conservation therapy |
|
|
Trofimova O.P., Tkachev S.I., Ivanov S.M., Utkina V.L., Cheban O.I., Glebovskaya V.V.
|
| Vol 24, No 3 (2022) |
Radiation-induced soft tissue sarcoma of the neck after radiation therapy for Hodgkin's lymphoma: a clinical case |
(Rus)
|
|
Ognerubov N.A., Antipova T.S.
|
| Vol 16, No 2 (2014) |
Radiological diagnostics of colorectal cancer liver metastases and immunohistochemical characteristics after drug treatment |
|
|
Skipenko T.O., Paltseva E.M., Sekacheva M.I., Bedganian A.L.
|
| Vol 6, No 1 (2004) |
Radiotermometriya v algoritme kompleksnogo obsledovaniya molochnykh zhelez |
|
|
Burdina L.M., Pinkhosevich E.G., Khaylenko V.A., Burdina I.I., Vesnin S.G., Tikhomirova N.N.
|
| Vol 15, No 4 (2013) |
RADIOTHERAPY AS THE ONLY TREATMENT IN CASE OF TONGUE CANCER PATIENTS |
|
|
Garbuzov M.I.
|
| Vol 8, No 2 (2006) |
Rak cherveobraznogo otrostka (osobennosti klinicheskogo techeniya, diagnostiki i lecheniya) |
|
|
Komov D.V., Kolesova O.V., Ivanova E.A.
|
| Vol 5, No 2 (2003) |
Rak mochevogo puzyrya |
|
|
Figurin K.M.
|
| Vol 13, No 3 (2011) |
Rak molochnoy zhelezy.Kak reshit' problemu finansirovaniya lecheniyasoglasno mezhdunarodnym standartam |
|
|
- -.
|
| Vol 5, No 2 (2003) |
Rak predstatel'noy zhelezy |
|
|
Bukharkin B.V.
|
| Vol 1, No 2 (1999) |
Rak shchitovidnoy zhelezy |
|
|
Podvyaznikov S.O.
|
| Vol 6, No 2 (2004) |
Rak shchitovidnoy zhelezy. Sovremennye podkhody v lechenii dannoy patologii |
|
|
Podvyaznikov S.O.
|
| Vol 4, No 4 (2002) |
Rak shchitovidnoy zhelezy u detey i vzroslykh Belgorodskoy oblasti v postchernobyl'skiy period |
|
|
Golivets T.P.
|
| Vol 2, No 2 (2000) |
Rak sheyki matki |
|
|
Kozachenko V.P.
|
| Vol 6, No 2 (2004) |
Rak sheyki matki: aktual'nost' problemy, printsipy lecheniya |
|
|
Kharitonova T.V.
|
| Vol 2, No 2 (2000) |
Rak tela matki |
|
|
Kharitonova T.V.
|
| Vol 2, No 2 (2000) |
Rak vul'vy: faktory prognoza, lechenie |
|
|
Kuznetsov V.V., Mekhtiev V.N., Korzhevskaya E.V., Mar'ina L.A., Lebedev A.I.
|
| Vol 9, No 3 (2007) |
Rak zheludka – sovremennye tendentsii v diagnostike i lechenii na primere opyta rossiyskikh klinik po dannym issledovaniya REGATE |
|
|
Ter-Ovanesov M.D., Yankin A.V., Tsikoridze M.Y., Shostka K.A., Lesnidze E.E., Solov'ev V.I., Munasypov F.R.
|
| Vol 13, No 3 (2011) |
Rak zheludka: sovremennoe sostoyanieproblemy i novye vozmozhnostiendoskopicheskoy diagnostiki |
|
|
Poddubnyy B.K., Kashin S.V., Ivanikov I.O.
|
| Vol 9, No 1 (2007) |
Rak zheludka: standarty i individual'nye aspekty taktiki khirurgicheskogo lecheniya |
|
|
Khvastunov R.A., Danilov S.P.
|
| Vol 14, No 4 (2012) |
Rakovye registry. Chast' 4. Rossiyskiy registr «Limfoproliferativnye zabolevaniya» |
|
|
Doronin V.A., Stefanov D.N., Nikitin E.A., Makarova M.M., Borisov D.A., Poddubnaya I.V.
|
| Vol 14, No 3 (2012) |
Rakovye registry v mire. Chast' 3. PHAROS - Gollandskiy populyatsionnyy registr onkogematologicheskikh bol'nykh |
|
|
Poddubnaya I.V., Stefanov D.N., Kalashnikov N.D.
|
| Vol 14, No 2 (2012) |
Rakovye registry: vchera, segodnya, zavtra. Chast' 2 |
|
|
Poddubnaya I.V., Stefanov D.N.
|
| Vol 14, No 1 (2012) |
Rakovye registry:vchera, segodnya, zavtra |
|
|
Poddubnaya I.V., Stefanov D.N.
|
| Vol 20, No 1 (2018) |
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series |
(Rus)
|
|
Orlova R.V., Zhukova L.G., Ganshina I.P., Yukalchuk D.Y., Ponomarenko D.M., Beliak N.P., Gordeeva O.O., Erdniev S.P., Minasyan A.A., Dashkova A.A., Sopiya E.R., Sholokhova E.A., Gurochkin A.B.
|
| Vol 10, No 1 (2008) |
Rannyaya diagnostika metastaticheskoy uveal'noy melanomy: sovremennye vozmozhnosti i perspektivy razvitiya (obzor literatury) |
|
|
Kazimirova E.G., Grishina E.E.
|
| Vol 25, No 2 (2023) |
Rare histological subtypes of bladder cancer in clinical practice: a case series |
(Rus)
|
|
Paychadze A.A., Golubeva S.A., Kamalova M.A.
|
| Vol 25, No 4 (2023) |
Rare inflammatory myofibroblastic lung tumor with multi-organ metastasis: A case report |
(Rus)
|
|
Budurova M.D., Trifanov V.S., Bagrov V.A., Lozhkin M.V., Chernichenko M.A., Surkova V.S., Poluektov S.I., Lyubchenko L.N.
|
| Vol 18, No 1 (2016) |
Rare morphological forms of breast cancer: features of surgical approach |
(Rus)
|
|
Vysotskaya I.V., Letyagin V.P., Kolyadina I.V., Martynova G.V.
|
| Vol 17, No 3 (2015) |
Rasprostranennost' melanomy |
|
|
Demidov L.V.
|
| Vol 5, No 4 (2003) |
Rasshirenie spektra terapevticheskikh vozmozhnostey oksaliplatina |
|
|
Gorbunova V.A.
|
| Vol 6, No 1 (2004) |
Rasshirennye D3 - khirurgicheskie vmeshatel'stva pri rake zheludka |
|
|
Khvastunov R.A., Shirokov O.V., Shereshkov A.Y., Begretov T.B.
|
| Vol 13, No 3 (2011) |
Ratsional'noe lekarstvennoe lechenienemelkokletochnogo raka legkogo |
|
|
Borisova E.I., Gutorov S.L.
|
| Vol 12, No 1 (2010) |
Razvitie lekarstvennoy terapiiraka pochki |
|
|
Poddubnaya I.V.
|
| Vol 9, No 4 (2007) |
Razvitie onkogematologii v Rossiyskom onkologicheskom tsentre im. N.N.Blokhina RAMN |
|
|
Osmanov E.A., Podtsubnaya I.V., Volkova M.A., Demina E.A., Tumyan G.S., Votyakova O.M., Shirin A.D., Larionova V.B., Sorokin E.N.
|
| Vol 24, No 4 (2022) |
Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study |
(Rus)
|
|
Orlova K.V., Fedyanin M.Y., Simanenkov K.E., Dergunov A.S., Goldshmidt P.R., Saydullaeva A.F., Bogacheva D.V., Yavorskaya M.A., Azanov A.Z., Fedenko A.A., Bolotina L.V., Deshkina T.I., Babina K.G., Kuzevanova E.A., Zhukova L.G., Feoktistova P.S., Polshina N.I., Peganova E.V., Shikina V.E., Sobolev M.M., Mironov O.V., Vaschenko V.A., Ershova M.M., Mezhueva A.O., Orlova S.A., Tantsyrev D.A., Taskina D.K., Teterich A.A., Karabina E.V., Kostalanova Y.V., Bogacheva M.V., Zhukova N.V., Orlova R.V., Zinkevich M.V., Kazmin A.I., Volkonskiy M.V., Voronkova L.M., Karpova A.S., Maleyko M.L., Gorshenina M.N., Kryuchkova E.I., Moiseenko F.V., Murzina Y.I., Musin S.I., Ogloblin A.N., Perminova M.S., Dumbrava R.A., Emelyanov S.A., Protsenko S.A., Sultanbaev A.V., Tarasova A.V., Shakhnovich E.B., Demchenkova M.V., Lozovskaya Y.A., Musaeva K.S., Pavlova E.M., Skotnikov R.A., Chernova V.V., Chichkanova A.S., Akhmatova A.M., Zafirova M.A., Mischenko A.A., Ovsienko E.N., Petrukhnenko V.A., Syusyukaylova O.A., Tyugina Y.A., Shumilkina E.A., Stroyakovskiy D.L., Yurchenkov A.N., Baldin P.L., Belova A.S., Diduk O.V., Konovalova E.A., Lebedeva L.N., Li Y.A., Mashtapa V.V., Mironenkova Y.A., Narovenkova K.V., Pavlikova O.A., Parsadanova E.L., Pimonova I.S., Ruzhnikova A.A., Sivunova I.D., Soloveva E.P., Sosnin M.I., Temirsultanova T.K., Tyulegenova M.Z., Khodkevich A.V., Shakurova N.R., Efendieva S.N., Avagimyan K.L., Anokhina E.P., Antoshkina M.I., Borzyanitsa S.M., Dzhentemirov S.K., Dmitrochenko M.V., Zheleznyak A.V., Komoza Y.V., Kopanev A.S., Kornienko T.I., Krasilnikova M.A., Lukhmanova D.A., Mazur N.S., Markina P.M., Mitapov Z.S., Osodoeva S.N., Prokopenko I.A., Radyukova I.M., Ramazanova M.S., Safarova A.R., Safronova M.A., Khabrieva K.M., Tsygankova N.S., Chermakova K.V., Chirkova T.A., Samoylenko I.V., Nazarova V.V., Akhmetyanova A.E., Demidov L.V.
|
| Vol 25, No 3 (2023) |
Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study |
(Rus)
|
|
Evdokimov V.I., Bloshchinenko A.A., Abolmasov A.E., Vilensky A.A., Laskov M.S.
|
| Vol 22, No 4 (2020) |
Recurrent desmoid-type retroperitoneal fibromatosis: clinical observation |
(Rus)
|
|
Budurova M.D., Fainshtein I.A., Turupaev K.A., Kalinin A.E., Kozlov N.A.
|
| Vol 24, No 2 (2022) |
Recurrent of ovarian cancer with lymph node involvement: surgery or chemotherapy? Retrospective cohort study |
(Rus)
|
|
Stilidi I.S., Egenov O.A., Nered S.N., Kalinin O.E., Shevchuk A.S., Arkhiri P.P., Suleymanov E.A., Tyulyandina А.S.
|
| Vol 1, No 2 (1999) |
Redkoe sochetanie sinkhronnykh bilateral'nykh zlokachestvennykh opukholey molochnykh zhelez |
|
|
Ognerubov N.A., Poddubnaya I.V., Ermilova V.D.
|
| Vol 22, No 3 (2020) |
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy |
(Rus)
|
|
Kononenko I.B., Snegovoy A.V., Grebennikova O.P., Sel’chuk V.Y., Palchinskaia O.V.
|
| Vol 23, No 2 (2021) |
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic |
(Rus)
|
|
Sekacheva M.I., Fatyanova A.S., Meretukov D.A., Zhilenkova A.V., Rusanov A.S., Rozhkov A.A., Guryanova A.A., Bagmet N.N.
|
| Vol 6, No 1 (2004) |
Regional'naya programma lecheniya bol'nykh disseminirovannym rakom yaichnika ( I I B - I V stadii ): aktual'nost', tsel', predvaritel'nye rezul'taty |
|
|
Poddubnaya I.V., Urmancheeva A.F.
|
| Vol 9, No 3 (2007) |
Regional'naya programma lecheniya bol'nykh pervichno-generalizovannym i metastaticheskim rakom molochnoy zhelezy |
|
|
- -.
|
| Vol 5, No 1 (2003) |
Regional'naya programma lecheniya mestno - rasprostranennogo i metastaticheskogo raka molochnoy zhelezy |
|
|
Davydov M.I., Poddubnaya I.V.
|
| Vol 9, No 3 (2007) |
Regional'naya programma lecheniya raka yaichnika IIB–IV stadii |
|
|
- -.
|
| Vol 18, No 3 (2016) |
Regorafenib application in patients with metastatic colorectal cancer in actual clinical practice |
(Rus)
|
|
Sekacheva M.I., Bagmet N.N.
|
| Vol 23, No 3 (2021) |
Regorafenib in metastatic colorectal cancer: more data for clinical decisions |
(Rus)
|
|
Petkau V.V., Karimova A.A., Akishina Z.V.
|
| Vol 19, No 3 (2017) |
Regorafenib: from clinical research to clinical practice |
(Rus)
|
|
Fedyanin M.Y., Tryakin A.A.
|
| Vol 18, No 5 (2016) |
Regulatory T-cells (Treg) in lymphoproliferative diseases |
|
|
Kuzmina E.G., Mushkarina T.Y., Konstantinova T.V.
|
| Vol 10, No 4 (2008) |
Rekomendatsii po obsledovaniyu i lecheniyu bol'nykh V-kletochnym khronicheskim limfoleykozom |
|
|
Bessmel'tsev S.S., Byalik T.E., Volkova M.A., Golubeva M.E., Zagoskina T.P., Zaritskiy A.Y., Kaplanov K.D., Korobkin A.V., Molostova V.Z., Nikitin E.A., Pospelova T.I., Samoylova O.S.
|
| Vol 14, No 4 (2012) |
Rekomendatsiipo khronicheskomu limfoleykozu |
|
|
Nikitin E.A., Hallek M., Baykov V.V., Bakirov B.A., Bessmel'tsev S.S., Zagoskina T.P., Kovrigina A.M., Konstantinova T.S., Krivolapov Y.A., Lugovskaya S.A., Matsionis A.E., Obukhova T.N., Osmanov E.A., Pospelova T.I., Samoylova O.S., Stadnik E.A., Tupitsyn N.N., Shatokhin Y.V., Poddubnaya I.V.
|
| Vol 8, No 1 (2006) |
Rekormon i kachestvo zhizni onkologicheskikh bol'nykh s anemiey |
|
|
Novik A.A., Ionova T.I.
|
| Vol 10, No 2 (2008) |
Rekormon i kachestvo zhizni onkologicheskikh patsientov s anemiey |
|
|
Novik A.A., Ionova T.I., Ivanova V.L., Udovitsa D.P., Abdulkadyrov K.M., Bakirov A.B., Achikyan V.F.
|
| Vol 25, No 3 (2023) |
Relationship of the integrin profile of the primary tumor to metastasis to regional lymph nodes in breast cancer |
(Rus)
|
|
Zavyalova M.V., Kuznecov G.A., Grigoryeva E.S., Tashireva L.A., Pismenny D.S., Perelmuter V.M.
|
| Vol 21, No 2 (2019) |
Relevance of endosonography in diagnosis of tumor and pretumor pathology of the larynx, oropharynx and laryngopharynx |
(Rus)
|
|
Allakhverdieva G.F., Sinyukova G.T., Malikhova O.A., Tumanian A.O., Cherkes L.V., Gudilina E.A., Danzanova T.Y., Opekunova V.V.
|
| Vol 24, No 4 (2022) |
Remote multimodal prehabilitation in the presence of cachexia and resectable gastric cancer: a clinical case |
(Rus)
|
|
Lyadov V.K., Boldyreva T.S., Achkasov E.E., Gorshkov A.Y., Chashchin M.G., Protsenko E.V., Starodubova V.V., Galkin V.N.
|
| Vol 25, No 3 (2023) |
Remote pre-habilitation in patients with cachexia and resectable gastric cancer: a case series |
(Rus)
|
|
Boldyreva T.S., Lyadov V.K., Derevyashkina G.V., Shestakova V.A., Gorshkov A.Y., Zyatenkova E.V., Procenko E.V.
|
| Vol 27, No 2 (2025) |
Renal cell carcinoma associated with von Hippel–Lindau syndrome: an ambispective study |
(Rus)
|
|
Volkova M.I., Turupaev K.A., Filippova M.G., Ladyko D.D., Sinitsyna O.R., Gridneva Y.V., Matveev V.B.
|
| Vol 16, No 1 (2014) |
Renal involvement in children with non-Hodgkin lymphomas |
|
|
Valiev T.T., Panferova T.P., Koshechkina N.A., Zakharova E.V., Mikhailova E.V., Kaminskaya I.V.
|
| Vol 9, No 4 (2007) |
Reproduktivnaya funktsiya u zhenshchin, bol'nykh limfomoy Khodzhkina |
|
|
Pylova I.V., Demina E.A., Perilova E.E., Shmakov R.G.
|
| Vol 10, No 2 (2008) |
Reshenie ekspertnogo soveshchaniya«Novye vozmozhnosti profilaktiki i lecheniya invazivnykh gribkovykh infektsiy» |
|
|
- -.
|
| Vol 25, No 3 (2023) |
Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors” |
(Rus)
|
|
Breder V.V., Zhukova L.G., Bolotina L.V., Demidova I.A., Zhulikov Y.A., Lubennikova E.V., Naskhletashvili D.R., Orlov S.V., Orlova R.V., Romanov I.S., Savelov N.A., Sarantseva K.A., Tyulyandina A.S., Fedyanin M.Y.
|
| Vol 25, No 4 (2023) |
Resolution on the experts' discussion of the TRIANGLE study results |
(Rus)
|
|
Editorial B.
|
| Vol 27, No 2 (2025) |
Results of lenvatinib as first-line targeted therapy for advanced hepatocellular cancer: a retrospective study |
(Rus)
|
|
Antonova E.Y., Janyan I.A., Laktionov K.K., Pogrebnyakov I.V., Savchenko I.V., Breder V.V.
|
| Vol 25, No 4 (2023) |
Results of pelvic exenteration in patients with cervical cancer: clinical experience |
(Rus)
|
|
Khakimov G.A., Khakimova G.G.
|
| Vol 15, No 2 (2013) |
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases |
|
|
Sekacheva M.I., Bagmet N.N., Polishchuk L.O., Glazova O.V., Zaklyazminskaya E.V., Skripenko O.G.
|
| Vol 24, No 4 (2022) |
Results of surgical treatment of patients with malignant peripheral nerve sheath tumors: a retrospective and prospective study |
(Rus)
|
|
Abdulzhaliev A.T., Sushentsov E.A., Boulytcheva I.V., Senderovich A.I., Nikulin M.P., Sofronov D.I., Bugaev V.E.
|
| Vol 3, No 2 (2001) |
Retinoevaya kislota kak faktor differentsirovki kletok gemopoeza |
|
|
Uteshev D.B., Korostelev S.A., Storozhakov G.I., Uteshev B.S., Baryshnikov A.Y.
|
| Vol 26, No 3 (2024) |
Retrospective analysis of the safety and efficacy of Pembroria® during non-medical switching from the original drug Keytruda® in patients with advanced malignancies of various localizations in real clinical practice |
(Rus)
|
|
Zhukova L.G., Filonenko D.A., Polshina N.I., Smolin S.A., Pasechnyuk O.S.
|
| Vol 15, No 3 (2013) |
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka |
|
|
Timofeev I.V.
|
| Vol 13, No 1 (2011) |
Retsidivy follikulyarnoy limfomy: problemy i puti resheniya |
|
|
Poddubnaya I.V.
|
| Vol 17, No 4 (2015) |
Review of the Event: The role of local biosimilar drugs and original biological drugs in modern cancer treatment |
|
|
- -.
|
| Vol 13, No 2 (2011) |
Rezhimy na osnove Taksotera®v terapii HER-2-pozitivnogo rakamolochnoy zhelezy |
|
|
Artamonova E.V.
|
| Vol 9, No 4 (2007) |
Rezolyutsiya ekspertnogo soveshchaniya po ispol'zovaniyu eritropoezstimuliruyushchikh preparatov (ESP) v onkologii ot 3 noyabrya 2007 g |
|
|
Poddubnaya I.V.
|
| Vol 4, No 3 (2002) |
Rezolyutsiya rabochego soveshchaniya po proektu regional'noy programmy lecheniya pervichno-generalizovannogo i metastaticheskogo raka molochnoy zhelezy |
|
|
- -.
|
| Vol 15, No 3 (2013) |
Rezul'taty «Epidemiologicheskoy programmy skrininga HER2-statusa u bol'nykh rakom molochnoy zhelezy» v Rossiyskoy Federatsii |
|
|
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A.
|
| Vol 14, No 2 (2012) |
Rezul'taty khirurgicheskogo lecheniya metastaticheskogo kolorektal'nogo raka posle provedeniya lekarstvennoy terapii s dobavleniem bevatsizumaba |
|
|
Sekacheva M.I., Polishchuk L.O., Bagmet N.N., Skipenko O.G.
|
| Vol 6, No 4 (2004) |
Rezul'taty lecheniya bol'nykh rakom molochnoy zhelezy s metastazami v kosti |
|
|
Vyshinskaya G.V., Mikhina Z.P., Danilova V.S., Nakhalova T.A., Chaklina E.A., Aplevich N.N., Rotobel'skaya L.E.
|
| Vol 9, No 4 (2007) |
Rezul'taty lecheniya Myustoforanom rasprostranennoy i metastaticheskoy form melanomy |
|
|
Radyukova I.M., Kosenok V.K., Tarasevich A.D., Merkulov V.N., Kurakin V.I., Trenina N.A.
|
| Vol 5, No 3 (2003) |
Rezul'taty primeneniya gemtsitabina i pemetrekseda po materiala m ASCO 2003 |
|
|
Karaseva V.V.
|
| Vol 6, No 3 (2004) |
Rezul'taty primeneniya oksaliplatina pri kolorektal'nom rake i drugikh solidnykh opukholyakh (po materialam ASCO 2003) |
|
|
Topchieva S.V.
|
| Vol 13, No 4 (2011) |
Rezul'taty rossiyskogo mnogotsentrovogoissledovaniya po izucheniyu vozmozhnostiispol'zovaniya klinicheskikh prediktorov dlyaotbora bol'nykh nemelkokletochnym rakomlegkogo na terapiyu erlotinibom |
|
|
Smolin A.V., Borisov V.I., Orlov S.V., Gutorov S.L., Fedenko A.A., Karaseva N.A., Khaliyarova D.D.
|
| Vol 6, No 4 (2004) |
Rezul'taty vnedreniya Regional'noy programmy po optimizatsii lecheniya rasprostranennogo raka yaichnikov v rossiyskikh onkologicheskikh dispanserakh na seredinu dekabrya 2004 g |
|
|
Kharitonova T.V., Poddubnaya I.V.
|
| Vol 25, No 4 (2023) |
Ribociclib + adjuvant hormone therapy in early breast cancer: prevention of recurrence. New opportunities. A review |
(Rus)
|
|
Ognerubov N.A.
|
| Vol 20, No 2 (2018) |
Ribociclib in 1st line HR+ breast cancer treatment |
(Rus)
|
|
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
|
| Vol 15, No 4 (2013) |
RIBOMUSTINE (BENDAMUSTINE) IS APPROVED FOR THE TREATMENT IN MULTIPLE MYELOMA PATIENTS IN RUSSIA FEDERATION |
|
|
- -.
|
| Vol 24, No 2 (2022) |
Risk of discrimination against Russian citizens in providing medical care abroad as a health care trend |
(Rus)
|
|
Ognerubov N.A., Zelepukin R.V., Poddubnaya I.V.
|
| Vol 10, No 2 (2008) |
Rituksimab pri lechenii autoimmunnykh tsitopeniy Obzor literatury |
|
|
Filatov L.B., Pivnik A.V.
|
| Vol 2, No 3 (2000) |
Rol' aredii v lechenii osteoliticheskikh metastazov zlokachestvennykh opukholey v kosti |
|
|
Kondrat'eva A.P.
|
| Vol 1, No 2 (1999) |
Rol' arimideksa (anastrozola) v sovremennoy endokrinnoyterapii bol'nykh rakom molochnoy zhelezy v menopauze |
|
|
Lichinitser M.R.
|
| Vol 6, No 2 (2004) |
Rol' bisfosfonatov v lechenii raka molochnoy zhelezy |
|
|
Kondrat'eva A.P., Poddubnaya I.V.
|
| Vol 8, No 3 (2006) |
Rol' epoetina beta (RekormonR) v terapii anemii u patsientov s solidnymi opukholyami |
|
|
Kazantseva M.V., Davidenko I.S.
|
| Vol 13, No 3 (2011) |
Rol' gefitiniba v lechenii bol'nykhnemelkokletochnym rakom legkogos mutatsiey v gene retseptoraepidermal'nogo faktora rosta |
|
|
Moiseenko F.V., Imyanitov E.N., Matsko D.E., Semenov I.I., Levchenko E.V., Moiseenko V.M., Protsenko C.A., Chubenko V.A., Brezhnev N.V., Ievleva A.G., Ivantsov A.O., Abduloeva N.K.
|
| Vol 3, No 3 (2001) |
Rol' granulotsitarnogo i granulotsitarno-makrofagal'nogo koloniestimuliruyushchikh faktorov v lechenii infektsii pri neytropenii |
|
|
Ptushkin V.V.
|
| Vol 4, No 4 (2002) |
Rol' i mesto kitrila v sovremennykh skhemakh lecheniya toshnoty i rvoty |
|
|
Ptushkin V.V.
|
| Vol 11, No 1 (2009) |
Rol' i mesto tsetuksimaba v 1-y linii terapii metastaticheskogo kolorektal'nogo raka |
|
|
Kopp M.V., Koroleva I.A.
|
| Vol 17, No 3 (2015) |
Rol' klinicheskikh rekomendatsiy v vybore taktiki lecheniya patsientov s melanomoy kozhi |
|
|
Kharkevich G.Y.
|
| Vol 12, No 3 (2010) |
Rol' lapatiniba v terapiimetastaticheskogo raka molochnoyzhelezy s ekspressiey gormonal'nykhretseptorov |
|
|
Poddubnaya I.V., Matveeva O.N.
|
| Vol 8, No 4 (2006) |
Rol' luchevoy terapii v lechenii bol'nykh ekstranodal'nymi zlokachestvennymi limfomami |
|
|
Il'in N.V., Vinogradova Y.N., Nikolaeva E.N., Ivanova E.I.
|
| Vol 7, No 3 (2005) |
Rol' noveyshikh tekhnologiy v endoskopicheskoy diagnostike i otsenke effektivnosti lecheniya limfom zheludka |
|
|
Malikhova O.A., Poddubnyy B.K., Kuvshinov Y.P., Frolova I.P.
|
| Vol 11, No 3 (2009) |
Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo |
|
|
Poddubnaya I.V.
|
| Vol 3, No 1 (2001) |
Rol' retseptora tsitokinov gp130 v gemopoeze |
|
|
Tupitsyn N.N.
|
| Vol 11, No 3 (2009) |
Rol' rituksimaba v lechenii nekhodzhkinskikh limfom(referativnyy obzor randomizirovannykh klinicheskikh issledovaniy) |
|
|
Mikhaylova N.B.
|
| Vol 11, No 2 (2009) |
Rol' Taksotera v lechenii metastaticheskogo raka molochnoy zhelezy |
|
|
Kolyadina I.V., Makarenko N.P., Poddubnaya I.V.
|
| Vol 5, No 1 (2003) |
Rol' virusov papillom v kantserogeneze sheyki matki |
|
|
Mazurenko N.N.
|
| Vol 23, No 1 (2021) |
Role and place of PARP inhibitors in the modern treatment algorithm of BRCA-associated HER2-negative metastatic breast cancer. Results of the educational and discussion events based on the “OncoForum” platform |
(Rus)
|
|
Board E.
|
| Vol 26, No 3 (2024) |
Role of enzyme replacement therapy for exocrine and nutritional insufficiency in patients with malignancies: A review |
(Rus)
|
|
Khatkov I.E., Maev I.V., Bordin D.S., Kononenko I.B., Kucheryavyy Y.A., Pokataev I.A., Snegovoy A.V., Tryakin A.A., Feoktistova P.S., Zhukova L.G.
|
| Vol 26, No 3 (2024) |
Role of immunohistochemical prognostic factors in various types of immunotherapy for metastatic melanoma: A retro-prospective study |
(Rus)
|
|
Oganesyan L.V., Zavalishina L.E., Ognerubov N.A., Kostalanova I.V., Kaganov O.I., Poddubnaya I.V.
|
| Vol 23, No 4 (2021) |
Role of pharmacogenetic factors in the development of side effects of methotrexate in the treatment of malignant tumors: A review |
(Rus)
|
|
Valiev T.T., Semenova V.V., Ikonnikova A.Y., Petrova A.A., Belysheva T.S., Nasedkina T.V.
|
| Vol 27, No 2 (2025) |
Role of repeat biopsies of metastatic and recurrent lesions for the study of tumor heterogeneity in luminal breast cancer: Retrospective and prospective analyses |
(Rus)
|
|
Gluzman M.I., Chistyakova E.A., Raskin G.A., Orlova R.V.
|
| Vol 15, No 2 (2013) |
Role of vemurafenib in the treatment of disseminated skin melanoma |
|
|
Demidov L.V., Utyashev I.A., Kharkevich G.Y.
|
| Vol 15, No 4 (2013) |
Rossiyskaya regional'naya programma: ad\"yuvantnaya khimioterapiya rannego raka molochnoy zhelezy rezhimami na osnove Taksotera (Re-Tac) |
|
|
- -.
|
| Vol 16, No 3 (2014) |
Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib |
|
|
Smolin A.V., Gorbacheva A.V.
|
| 901 - 1050 of 1398 Items |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
